TheJasperCo
Well-known member
Good points, it’s not just about PC but I guess they used to say the same about breast cancer before they introduced screening - but prostate cancer now kills more men than breast cancer kills women.
There are only three cancers for which regular, routine screening is carried out: breast, bowel and cervical. As someone close to the research side of things, it's understandable to want near-universal screening for every cancer type. Unfortunately there's factors at play that make it difficult to do for tumours such as lung and prostate. Chief among these is the inherent need for a minimal rate of false positive/negative (FP/FN) results. Alongside reliability, comes cost - which is naturally important for NICE to consider. Do the potential costs incurred by rolling out a screening programme outweigh the cost savings with early diagnosis?
In fact there an excellent CRUK link HERE for you to peruse if you're interested in the subject in more detail.